OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS
Pharmacogenetics allows to determine the cause of the ineffectiveness of drug therapy for certain groups of people who do not respond to treatment or exhibiting an inadequate response to a standard dose of the drug. Pharmacogenetic test can predict the speed and features of a metabolism of antiepile...
Saved in:
Main Authors: | T. V. Dokukina, M. V. Makhrov, I. V. Gaidukevich, A. A. Gilep, T. S. Golubeva, F. P. Khlebokazov, N. N. Misyuk, P. P. Korolevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2016-05-01
|
Series: | Эпилепсия и пароксизмальные состояния |
Subjects: | |
Online Access: | https://www.epilepsia.su/jour/article/view/10 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTICONVULSANTS AND ANTIPSYCHOTICS ON THE BASIS OF PHARMACOGENETIC TESTING
by: T. V. Dokukina, et al.
Published: (2016-08-01) -
The pharmacogenetics antiepileptic drugs
by: N. A. Shnayder, et al.
Published: (2008-12-01) -
Genetic determinism of epilepsy refractoriness in patients with congenital cerebral p
by: P. L. Sokolov, et al.
Published: (2023-12-01) -
Assessment of bone mineral density in epileptic patients with long-term antiepileptic therapy: pilot data
by: N. A. Sivakova, et al.
Published: (2023-12-01) -
PROBABLE ANTICONVULSIVE MECHANISMS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION AND PREDICTORS OF ITS EFFECTIVITY
by: O. V. Kisten, et al.
Published: (2016-05-01)